Notice of Interest in Advancing Research on FMR1-Associated Conditions
(NOT-HD-20-009) Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Advancing Translational Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations
(NOT-MD-20-022)
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Research on Women's Health
Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19
(NOT-MH-20-053)
National Institute of Mental Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Research on Women's Health
Funding Opportunities
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)
(PAR-20-211)
NIH Basic Behavioral and Social Science Opportunity Network
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of Behavioral and Social Sciences Research
Application Receipt Date(s):
March 17, 2021, March 17, 2022, March 17, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
National Institute of General Medical Sciences Institutional Predoctoral Research Training Grant (T32 - Clinical Trial Not Allowed)
(PAR-20-213)
National Institute of General Medical Sciences
Application Receipt Date(s):
Standard dates apply
All applications are due by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
(PAR-20-225)
National Institute on Drug Abuse
Application Receipt Date(s):
November 2, 2020, October 19, 2021, October 19, 2022 by 5:00 PM local time of applicant organization.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required)
(PAR-20-226)
NIH Basic Behavioral and Social Science Opportunity Network
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of Behavioral and Social Sciences Research
Application Receipt Date(s):
March 17, 2021, March 17, 2022, March 17, 2023,
by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)
(RFA-CA-20-038)
National Cancer Institute
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s):
July 22, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
No late applications will be accepted for this FOA.
George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
(RFA-DK-20-008)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s):
November 4, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Advancing Genomic Medicine Research (Clinical Trial Optional) (R01)
(RFA-HG-20-036)
National Human Genome Research Institute
Application Receipt Date(s):
August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Advancing Genomic Medicine Research (Clinical Trial Optional) (R21)
(RFA-HG-20-037)
National Human Genome Research Institute
Application Receipt Date(s):
August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
(RFA-HL-21-003)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s):
October 2, 2020